ASHLEY GREENWALT: Open Payments
NPI 1558887281 · THE COLONY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$789 in 45 payments from 13 companies in 2025. Trend: 2023 $1,296 · 2024 $333 · 2025 $789
Food & beverage: $789
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $177 |
| Novo Nordisk Inc | 11 | $169 |
| ABBVIE INC. | 11 | $153 |
| Amgen Inc. | 4 | $58 |
| Lilly USA, LLC | 3 | $49 |
| SANOFI-AVENTIS U.S. LLC | 2 | $45 |
| Exact Sciences Corporation | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $18 |
Products named: AIRSUPRA, Wegovy, UBRELVY, QULIPTA, MOUNJARO, TZIELD, Ozempic, FARXIGA.
Industry payments across TX — which companies pay providers there.
